Dietary effects of mead acid on N-methyl-N-nitrosourea-induced mammary cancers in female Sprague-Dawley rats

Kinoshita,Yuichi; Yoshizawa,Katsuhiko; Hamazaki,Kei; Emoto,Yuko; Yuri,Takashi; Yuki,Michiko; Kawashima,Hiroshi; Shikata,Nobuaki; Tsubura,Airo

doi:10.3892/br.2015.530

Dietary effects of mead acid on N-methyl-N-nitrosourea-induced mammary cancers in female Sprague-Dawley rats

Authors:
- Yuichi Kinoshita
- Katsuhiko Yoshizawa
- Kei Hamazaki
- Yuko Emoto
- Takashi Yuri
- Michiko Yuki
- Hiroshi Kawashima
- Nobuaki Shikata
- Airo Tsubura
View Affiliations

Affiliations: Department of Pathology II, Kansai Medical University, Hirakata, Osaka 537‑1010, Japan, Department of Public Health, Faculty of Medicine, University of Toyama, Sugitani, Toyama 930‑0194, Japan, Institute for Health Care Science, Suntory Wellness Ltd., Seika‑cho, Kyoto 619‑0284, Japan, Division of Diagnostic Cytopathology and Histopathology, Kansai Medical University Takii Hospital, Moriguchi, Osaka 570‑8507, Japan
Published online on: October 14, 2015 https://doi.org/10.3892/br.2015.530
Pages: 33-39

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The effect of mead acid (MA; 5,8,11-eicosatrienoic acid) on the suppression of the development and growth of N-methyl-N-nitrosourea (MNU)-induced mammary cancer in female Sprague-Dawley rats was examined. The MA diet (2.4% MA) or control (CTR) diet (0% MA) was started at 6 weeks of age, MNU was injected intraperitoneally at 7 weeks of age, and the rats were maintained on the respective diets for the whole experimental period (until 19 weeks of age). All induced mammary tumors were luminal A subtype carcinomas (estrogen and progesterone receptor positive and HER2/neu negative). The MA diet significantly suppressed the initiation and promotion phases of mammary carcinogenesis; MA suppressed the development (incidence, 61.5 vs. 100%; multiplicity, 2.1 vs. 4.5) and the growth (final tumor weight, 427.1 vs. 1,796.3 mg) of mammary cancers by suppressing cell proliferation, but not by accelerating cell death. There were evident changes in the major fatty acid composition of n‑3, n‑6, and n‑9 fatty acids in the serum of the MA diet group; there was a significant increase in MA and significant decreases in oleic acid (OA), linoleic acid, arachidonic acid and docosahexaenoic acid. In non‑tumorous mammary tissue, there was a significant increase in MA and a significant decrease in OA in the MA diet group. The n‑6/n‑3 ratios in serum and mammary tissue of the MA diet group were significantly decreased. The MA diet suppressed MNU‑induced luminal A mammary cancer by lowering cancer cell proliferation. Therefore, MA may be a chemopreventive and chemotherapeutic agent. In addition to hormone therapy, MA supplementation may be a beneficial chemotherapeutic agent for the luminal A subtype of breast cancer.

View Figures

View References

1	Freedman LS, Kipnis V, Schatzkin A and Potischman N: Methods of epidemiology: Evaluating the fat-breast cancer hypothesis-comparing dietary instruments and other developments. Cancer J. 14:69–74. 2002. View Article : Google Scholar
2	Yang B, Ren XL, Fu YQ, Gao JL and Li D: Ratio of n-3/n-6 PUFAs and risk of breast cancer: A meta-analysis of 274135 adult females from 11 independent prospective studies. BMC Cancer. 14:1052014. View Article : Google Scholar : PubMed/NCBI
3	Takata T, Minoura T, Takada H, Sakaguchi M, Yamamura M, Hioki K and Yamamoto M: Specific inhibitory effect of dietary eicosapentaenoic acid on N-nitroso-N-methylurea-induced mammary carcinogenesis in female Sprague-Dawley rats. Carcinogenesis. 11:2015–2019. 1990. View Article : Google Scholar : PubMed/NCBI
4	Yuri T, Danbara N, Tsujita-Kyutoku M, Fukunaga K, Takada H, Inoue Y, Hada T and Tsubura A: Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutr Cancer. 45:211–217. 2003. View Article : Google Scholar : PubMed/NCBI
5	Cohen LA, Thompson DO, Maeura Y, Choi K, Blank ME and Rose DP: Dietary fat and mammary cancer. I. Promoting effects of different dietary fats on N-nitrosomethylurea-induced rat mammary tumorigenesis. J Natl Cancer Inst. 77:33–42. 1986.PubMed/NCBI
6	Zhu Z, Jiang W, McGinley JN, Prokopczyk B, Richie JP Jr, El Bayoumy K, Manni A and Thompson HJ: Mammary gland density predicts the cancer inhibitory activity of the N-3 to N-6 ratio of dietary fat. Cancer Prev Res (Phila). 4:1675–1685. 2011. View Article : Google Scholar : PubMed/NCBI
7	Senzaki H, Iwamoto S, Ogura E, Kiyozuka Y, Arita S, Kurebayashi J, Takada H, Hioki K and Tsubura A: Dietary effects of fatty acids on growth and metastasis of KPL-1 human breast cancer cells in vivo and in vitro. Anticancer Res. 18:1621–1627. 1998.PubMed/NCBI
8	Chang NW, Wu CT, Chen DR, Yeh CY and Lin C: High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation. J Nutr Biochem. 24:274–281. 2013. View Article : Google Scholar : PubMed/NCBI
9	Trichopoulou A, Lagiou P, Kuper H and Trichopoulos D: Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev. 9:869–873. 2000.PubMed/NCBI
10	Buckland G, Travier N, Agudo A, Fonseca-Nunes A, Navarro C, Lagiou P, Demetriou C, Amiano P, Dorronsoro M, Chirlaque MD, et al: Olive oil intake and breast cancer risk in the Mediterranean countries of the European prospective investigation into cancer and nutrition study. Int J Cancer. 131:2465–2469. 2012. View Article : Google Scholar : PubMed/NCBI
11	Rose DP and Connolly JM: Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res. 50:7139–7144. 1990.PubMed/NCBI
12	Fulco AJ and Mead JF: Metabolism of essential fatty acids. VIII. Origin of 5,8,11-eicosatrienoic acid in the fat-deficient rat. J Biol Chem. 234:1411–1416. 1959.PubMed/NCBI
13	Ichi I, Kono N, Arita Y, Haga S, Arisawa K, Yamano M, Nagase M, Fujiwara Y and Arai H: Identification of genes and pathways involved in the synthesis of Mead acid (20:3 n-9), an indicator of essential fatty acid deficiency. Biochim Biophys Acta. 1841:204–213. 2014. View Article : Google Scholar : PubMed/NCBI
14	Pouchieu C, Chajès V, Laporte F, Kesse-Guyot E, Galan P, Hercberg S, Latino-Martel P and Touvier M: Prospective associations between plasma saturated, monounsaturated and polyunsaturated fatty acids and overall and breast cancer risk-modulation by antioxidants: A nested case-control study. PLoS One. 9:e904422014. View Article : Google Scholar : PubMed/NCBI
15	Heyd VL and Eynard AR: Effects of eicosatrienoic acid (20:3 n-9, Mead's acid) on some promalignant-related properties of three human cancer cell lines. Prostaglandins Other Lipid Mediat. 71:177–188. 2003. View Article : Google Scholar : PubMed/NCBI
16	Kinoshita Y, Yoshizawa K, Hamazaki K, Emoto Y, Yuri T, Yuki M, Shikata N, Kawashima H and Tsubura A: Mead acid inhibits the growth of KPL-1 human breast cancer cells in vitro and in vivo. Oncol Rep. 32:1385–1394. 2014.PubMed/NCBI
17	Kurebayashi J, Kanomata N, Moriya T, Kozuka Y, Watanabe M and Sonoo H: Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype. BMC Cancer. 10:5682010. View Article : Google Scholar : PubMed/NCBI
18	Sandhu R, Parker JS, Jones WD, Livas CA and Coleman WB: Microarray-based profiling for molecular classification of breast cancer and identification of new targets for therapy. Lab Medicine. 41:364–372. 2010. View Article : Google Scholar
19	Sakuradani E, Kamada N, Hirano Y, Nishihara M, Kawashima H, Akimoto K, Higashiyama K, Ogawa J and Shimizu S: Production of 5,8,11-eicosatrienoic acid by a delta5 and delta6 desaturation activity-enhanced mutant derived from a delta12 desaturation activity-defective mutant of Mortierella alpina 1S-4. Appl Microbiol Biotechnol. 60:281–287. 2002. View Article : Google Scholar : PubMed/NCBI
20	Kanematsu S, Yoshizawa K, Uehara N, Miki H, Sasaki T, Kuro M, Lai YC, Kimura A, Yuri T and Tsubura A: Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol Rep. 26:603–608. 2011.PubMed/NCBI
21	Redon CE, Weyemi U, Parekh PR, Huang D, Burrell AS and Bonner WM: γ-H2AX and other histone post-translational modifications in the clinic. Biochim Biophys Acta. 1819:743–756. 2012. View Article : Google Scholar : PubMed/NCBI
22	Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al: American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
23	Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, et al: Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline update. J Clin Oncol. 31:3997–4013. 2013. View Article : Google Scholar : PubMed/NCBI
24	Russo J: Significance of rat mammary tumors for human risk assessment. Toxicol Pathol. 4:145–170. 2015. View Article : Google Scholar
25	Bligh EG and Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37:911–917. 1959. View Article : Google Scholar : PubMed/NCBI
26	Tsubura A, Uehara N, Kiyozuka Y and Shikata N: Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia. 10:87–100. 2005. View Article : Google Scholar : PubMed/NCBI
27	Cazzaniga M and Bonanni B: Breast cancer chemoprevention: Old and new approaches. J Biomed Biotechnol. 2012:9856202012. View Article : Google Scholar : PubMed/NCBI
28	Hamazaki T, Nagasawa T, Hamazaki K and Itomura M: Inhibitory effect of 5,8,11-eicosatrienoic acid on angiogenesis. Prostaglandins Leukot Essent Fatty Acids. 86:221–224. 2012. View Article : Google Scholar : PubMed/NCBI
29	Okuyama H, Kobayashi T and Watanabe S: Dietary fatty acids-the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan. Prog Lipid Res. 35:409–457. 1996. View Article : Google Scholar : PubMed/NCBI
30	Lips EH, Mulder L, de Ronde JJ, Mandjes IA, Koolen BB, Wessels LF, Rodenhuis S and Wesseling J: Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response. Breast Cancer Res Treat. 140:63–71. 2013. View Article : Google Scholar : PubMed/NCBI
31	Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B and Senn HJ: Panel members: Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 22:1736–1747. 2011. View Article : Google Scholar : PubMed/NCBI